Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
30 9월 2008 - 11:00PM
PR Newswire (US)
WASHINGTON, Sept. 30 /PRNewswire-FirstCall/ -- Syngenta announced a
multi-year agreement with Metabolon for biochemical profiling
technology that will enhance the Syngenta technical toolkit for its
seeds research programs. This agreement will support Syngenta
researchers' understanding of plants' response to environmental
conditions and decisions on crop traits earlier in the development
cycle. "Biochemical profiling is becoming an important part of
Syngenta's focused program to apply the full range of cutting-edge
science to supply solutions for growers," said Roger Kemble, Ph.D.,
Head, Syngenta Crop Genetics Research. "Metabolon's technology will
enable Syngenta's insights to the performance of our products as we
focus in bringing the next generations of seed science across
native traits and GM paths to unlock crop productivity." "We are
excited to expand our partnership with Syngenta, a leading seed
biotechnology company," said John Ryals, Ph.D., president and chief
executive of Metabolon. "This agreement brings Syngenta into our
growing stable of commercial partners in the pharmaceutical,
biotechnology and consumer product sectors and we look forward to
providing further actionable insight with our global biochemical
analysis." This agreement expands upon initial studies performed by
Metabolon for Syngenta to test the application of the technology.
Financial terms of the agreement were not disclosed. Syngenta is a
world-leading agribusiness committed to sustainable agriculture
through innovative research and technology. The company is a leader
in crop protection, and ranks third in the high-value commercial
seeds market. Sales in 2007 were approximately $9.2 billion.
Syngenta employs over 21,000 people in more than 90 countries.
Syngenta is listed on the Swiss stock exchange (SYNN) and in New
York (SYT). Further information is available at
http://www.syngenta.com/. Cautionary Statement Regarding
Forward-Looking Statements This document contains forward-looking
statements, which can be identified by terminology such as
'expect', 'would', 'will', 'potential', 'plans', 'prospects',
'estimated', 'aiming', 'on track' and similar expressions. Such
statements may be subject to risks and uncertainties that could
cause the actual results to differ materially from these
statements. We refer you to Syngenta's publicly available filings
with the U.S. Securities and Exchange Commission for information
about these and other risks and uncertainties. Syngenta assumes no
obligation to update forward-looking statements to reflect actual
results, changed assumptions or other factors. This document does
not constitute, or form part of, any offer or invitation to sell or
issue, or any solicitation of any offer, to purchase or subscribe
for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall
it form the basis of, or be relied on in connection with, any
contract therefor. Media contacts: Anne Burt 202 628 2372
DATASOURCE: Syngenta CONTACT: Anne Burt of Syngenta,
+1-202-628-2372 Web site: http://www.syngenta.com/
Copyright